To get a pulse on the U.S.
Howard Shaps, MD, senior medical director, WellCare of Kentucky, shares details about the Medicaid insurers’ pilot program designed to fight the opioid epidemic.
Fluctuations in drug pricing and medication shortages are among the reasons for rising drug prices. Learn how you can protect your hospital’s bottom line.
Last year was a banner year for generic drug approvals by the FDA. Find out what’s in store for 2017.
Systematic review provides comprehensive first look at TNF-alpha biosimilar treatments.
Biosimilars will have a significant impact on cancer treatment, with the potential to drive cost savings, but will patients and providers be accepting?
IMS Health expert predicts future drug spending trends and ways to curb rising costs at the AMCP 2016 conference.
Drug shortages and manufacturer consolidation are leaving their imprint on the price of some generic drugs.
PBMs are moving products to non-covered status
The two companies have signed an agreement that commits them to a “50/50 joint venture” that may dominate the US market.